These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31249878)

  • 1. Long-term therapeutic effect in nonhuman primate eye from a single injection of anti-VEGF controlled release hydrogel.
    Yu Y; Lin X; Wang Q; He M; Chau Y
    Bioeng Transl Med; 2019 May; 4(2):e10128. PubMed ID: 31249878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single ocular injection of a sustained-release anti-VEGF delivers 6months pharmacokinetics and efficacy in a primate laser CNV model.
    Adamson P; Wilde T; Dobrzynski E; Sychterz C; Polsky R; Kurali E; Haworth R; Tang CM; Korczynska J; Cook F; Papanicolaou I; Tsikna L; Roberts C; Hughes-Thomas Z; Walford J; Gibson D; Warrack J; Smal J; Verrijk R; Miller PE; Nork TM; Prusakiewicz J; Streit T; Sorden S; Struble C; Christian B; Catchpole IR
    J Control Release; 2016 Dec; 244(Pt A):1-13. PubMed ID: 27810558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable Anti-Inflammatory Supramolecular Nanofiber Hydrogel to Promote Anti-VEGF Therapy in Age-Related Macular Degeneration Treatment.
    Gao H; Chen M; Liu Y; Zhang D; Shen J; Ni N; Tang Z; Ju Y; Dai X; Zhuang A; Wang Z; Chen Q; Fan X; Liu Z; Gu P
    Adv Mater; 2023 Jan; 35(2):e2204994. PubMed ID: 36349821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflibercept in wet AMD: specific role and optimal use.
    Semeraro F; Morescalchi F; Duse S; Parmeggiani F; Gambicorti E; Costagliola C
    Drug Des Devel Ther; 2013; 7():711-22. PubMed ID: 23990705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
    Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
    Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
    Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models.
    Giddabasappa A; Lalwani K; Norberg R; Gukasyan HJ; Paterson D; Schachar RA; Rittenhouse K; Klamerus K; Mosyak L; Eswaraka J
    Exp Eye Res; 2016 Apr; 145():373-379. PubMed ID: 26927930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of the exsudative age-related macular degeneration with choroidal neovascular membrane, its possibilities and economical indexes].
    Karel I
    Cesk Slov Oftalmol; 2007 Sep; 63(5):311-9. PubMed ID: 17915581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery System.
    Rudeen KM; Liu W; Mieler WF; Kang-Mieler JJ
    Curr Eye Res; 2022 Jul; 47(7):1034-1042. PubMed ID: 35343355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Vascular Endothelial Growth Factor Drug Conbercept-Loaded Peptide Hydrogel Reduced Angiogenesis in the Neovascular Age-Related Macular Degeneration.
    Fan W; Li S; Tao J; Yu C; Sun M; Xie Z; Wu X; Ge L; Wu Y; Liu Y
    J Biomed Nanotechnol; 2022 Jan; 18(1):277-287. PubMed ID: 35180922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
    Feng L; Hu JH; Chen J; Xie X
    J Zhejiang Univ Sci B; 2018 Apr.; 19(4):327-332. PubMed ID: 29616508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-month sustained delivery of anti-VEGF from in-situ forming hydrogel in the suprachoroidal space.
    Jung JH; Kim SS; Chung H; Hejri A; Prausnitz MR
    J Control Release; 2022 Dec; 352():472-484. PubMed ID: 36309098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Efficacy of an Injectable Microsphere-Hydrogel Ocular Drug Delivery System.
    Osswald CR; Guthrie MJ; Avila A; Valio JA; Mieler WF; Kang-Mieler JJ
    Curr Eye Res; 2017 Sep; 42(9):1293-1301. PubMed ID: 28557571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results.
    Eyetech Study Group
    Ophthalmology; 2003 May; 110(5):979-86. PubMed ID: 12750101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.
    Keenan TD; Vitale S; Agrón E; Domalpally A; Antoszyk AN; Elman MJ; Clemons TE; Chew EY;
    Ophthalmol Retina; 2020 Jan; 4(1):3-12. PubMed ID: 31395505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet AMD.
    Reid CA; Nettesheim ER; Connor TB; Lipinski DM
    Sci Rep; 2018 Aug; 8(1):11763. PubMed ID: 30082848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates.
    Nork TM; Dubielzig RR; Christian BJ; Miller PE; Miller JM; Cao J; Zimmer EP; Wiegand SJ
    Arch Ophthalmol; 2011 Aug; 129(8):1042-52. PubMed ID: 21825187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.